{
  "id": 9166203,
  "title": "Should Dividend Investors Buy Pfizer Stock for Its High Yield or Invest in Eli Lilly for Its Dividend Growth?",
  "url": "https://urgent.news/2026/09/22/should-dividend-investors-buy-pfizer-stock-for-its-high-yield-or-9166203",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-22T16:22:24.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/should-dividend-investors-buy-pfizer-stock-its-high-yield-or-invest-eli-lilly-its-dividend"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsEli Lilly's yield of 0.6% looks minimal, but that's only because of how incredibly well the stock has performed.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}